Cite
HARVARD Citation
Puvvada, S. et al. (n.d.). A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. Leukemia & lymphoma. 57 (10), pp. 2359-2369. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Puvvada, S. et al. (n.d.). A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. Leukemia & lymphoma. 57 (10), pp. 2359-2369. [Online].